Amber E. de Groot
Impact in
- Oncology top 5%
- Cancer Cells and Metastasis
- Cancer Immunotherapy and Biomarkers
- Cancer Research top 10%
- Cancer, Hypoxia, and Metabolism
Papers in ⓘ
-
- Immune cells in cancer 4
- Immune Cell Function and Interaction 3
- Oncology 8
- Cancer Cells and Metastasis 3
- CAR-T cell therapy research 2
- Co-authors
- Kenneth J. Pienta (7 shared papers)Kenneth C. Valkenburg (1 shared paper)Carolyn R. Bertozzi (2 shared papers)Peter V. Robinson (2 shared papers)Julia L. McKechnie (2 shared papers)Sarah R. Amend (4 shared papers)Joel S. Brown (1 shared paper)Cheng‐ting Tsai (1 shared paper)
- Journals
- Journal of the American Chemical Society (2 papers)Cancer Research (2 papers)Molecular Cancer Research (1 paper)Neoplasia (1 paper)Nature Reviews Clinical Oncology (1 paper)
- Partner nations
- United States
In The Last Decade
Amber E. de Groot
12 papers receiving 1.1k citations
Hit Papers
Peers
Comparison fields: 5 of 83
- Oncology 520
- Cancer Research 252
- Immunology 287
- Molecular Biology 510
- Biotechnology 47
Countries citing papers authored by Amber E. de Groot
This map shows the geographic impact of Amber E. de Groot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amber E. de Groot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amber E. de Groot more than expected).
Fields of papers citing papers by Amber E. de Groot
This network shows the impact of papers produced by Amber E. de Groot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amber E. de Groot. The network helps show where Amber E. de Groot may publish in the future.
Co-authors
The 25 scholars most cited alongside Amber E. de Groot, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Targeting the tumour stroma to improve cancer therapy Hit paper breakdown → | 2018 | 785 |
| 2 | 2018 | 84 | |
| 3 | 2017 | 76 | |
| 4 | 2015 | 70 | |
| 5 | 2016 | 55 | |
| 6 | 2022 | 18 | |
| 7 | 2021 | 11 | |
| 8 | 2024 | 8 | |
| 9 | 2023 | 6 | |
| 10 | 2017 | 4 | |
| 11 | 2023 | 1 | |
| 12 | 2022 | 1 |
About Amber E. de Groot
Amber E. de Groot is a scholar working on Immunology, Oncology, Cancer Research, Biotechnology and Molecular Biology, having authored 12 papers that have together received 1.1k indexed citations. Recurring topics across this work include Immune cells in cancer (4 papers), Cancer Cells and Metastasis (3 papers), Epigenetics and DNA Methylation (3 papers), Immune Cell Function and Interaction (3 papers), Prostate Cancer Treatment and Research (2 papers), Histone Deacetylase Inhibitors Research (2 papers), CAR-T cell therapy research (2 papers) and Glycosylation and Glycoproteins Research (2 papers). The work is most often cited by research in Oncology (520 citations), Cancer Research (252 citations), Immunology (287 citations), Molecular Biology (510 citations) and Biotechnology (47 citations). Amber E. de Groot has collaborated with scholars based in United States. Frequent co-authors include Kenneth J. Pienta, Kenneth C. Valkenburg, Carolyn R. Bertozzi, Peter V. Robinson, Julia L. McKechnie, Sarah R. Amend, Joel S. Brown, Cheng‐ting Tsai, K. Myers and W. Nathaniel Brennen. Their work appears in journals such as Journal of the American Chemical Society, Cancer Research, Molecular Cancer Research, Neoplasia and Nature Reviews Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.